SLCO1B1 polymorphisms influence tacrolimus exposure in kidney transplant recipients (2016)
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Sciences and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Assunto: POLIMORFISMO
ABNT
KOYAMA, Patrícia Tiemi et al. SLCO1B1 polymorphisms influence tacrolimus exposure in kidney transplant recipients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 23 ago. 2024. , 2016APA
Koyama, P. T., Campos-Salazar, A. B., Giuliani, L., Dietzius, A., Genvigir, F. D. V., Bonezi, V., et al. (2016). SLCO1B1 polymorphisms influence tacrolimus exposure in kidney transplant recipients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Koyama PT, Campos-Salazar AB, Giuliani L, Dietzius A, Genvigir FDV, Bonezi V, Felipe CR, Tedesco-Silva Jr H, Medina-Pestana JO, Fajardo CM, Hirata MH, Hirata RDC. SLCO1B1 polymorphisms influence tacrolimus exposure in kidney transplant recipients. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 50 res. FCF095.[citado 2024 ago. 23 ]Vancouver
Koyama PT, Campos-Salazar AB, Giuliani L, Dietzius A, Genvigir FDV, Bonezi V, Felipe CR, Tedesco-Silva Jr H, Medina-Pestana JO, Fajardo CM, Hirata MH, Hirata RDC. SLCO1B1 polymorphisms influence tacrolimus exposure in kidney transplant recipients. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 50 res. FCF095.[citado 2024 ago. 23 ]